Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 1 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 33Colorectal Neoplasms 12Neoplasms 11Pain, Postoperative 10Lung Neoplasms 9Brain Neoplasms 8Stomach Neoplasms 7Prostatic Neoplasms 7Pancreatic Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Melanoma 6Leukemia, Myeloid, Acute 5Ovarian Neoplasms 4Myoma 4Lymphoma, Non-Hodgkin 4Leiomyoma 4Hemorrhage 4Head and Neck Neoplasms 4Glioblastoma 4Colonic Neoplasms 4Agnosia 4Skin Neoplasms 3Recurrence 3Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neurotoxicity Syndromes 3Neoplasm Metastasis 3Nasopharyngeal Carcinoma 3Myelodysplastic Syndromes 3Multiple Endocrine Neoplasia Type 1 3

Interventions

telapristone acetate 18ulipristal acetate 17Uterine Myomectomy 13vilaprisan 12Leuprolide 11relugolix 9estradiol, norethindrone drug combination 9asoprisnil 9elagolix 7Uterine Artery Embolization 7Mifepristone 7Estradiol 7Bupivacaine 7ulipristal 6Tranexamic Acid 6Saline Solution 5Norethindrone Acetate 5linzagolix 4epigallocatechin gallate 4Sodium Chloride 4Letrozole 4Hysterectomy 4Vitamin B 6 3Sugars 3Misoprostol 3Lidocaine 3Gonadotropin-Releasing Hormone 3Embolization, Therapeutic 3cetrorelix 2Vitamin D 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Leiomyoma × Sodium Chloride × Clear all
NCT04655144 2026-01-07

Dex-Fib

University of Miami

Phase 3 Completed
42 enrolled 9 charts

Leiomyoma

NCT05979493 2025-08-06

QL Block in Laparoscopic Myomectomy

University Hospitals Cleveland Medical Center

Phase 4 Recruiting
80 enrolled

Leiomyoma, Pain, Postoperative

NCT05517590 2024-05-24

Intravenous Tranexamic Acid and Intramyometrial Desmopressin Effect on Blood Loss During Laparoscopic Myomectomy.

Acibadem University

Phase NA Completed
102 enrolled

Hemorrhage, Leiomyoma

NCT02889848 2019-07-10

Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids)

Advance Biofactures Corporation

Phase 1 Completed
15 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡